Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 Biotech Investing
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 Life Science Investing
Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences Life Science Investing
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc. Life Science Investing
EraNova Metals Identifies Rare Earth Element Potential at Adanac Through Re-Evaluation of Existing Assay Data; Announces Investor Relations Agreement; Announces Stock Option Grant Life Science Investing
Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update Life Science Investing
Biologics License Application for Subcutaneous Formulation of "LEQEMBI®" for the Treatment of Early Alzheimer's Disease Designated for Priority Review in China Life Science Investing
